文献速递生殖医学

囊胚玻璃化冷冻、冻存与复苏不影响活产率、婴儿出生体重或分娩时机

Blastocyst vitrification, cryostorage and warming does not affect live birth rate, infant birth weight or timing of delivery.
PubMed 文献 · Reprod Biomed Online · 2018-04-21

回顾性队列研究比较供卵 recipient 新鲜与玻璃化冻融整倍体囊胚移植、单胎活产的新鲜与冻融单胚胎移植,以及自体冻存整倍体单胚胎移植(冻存21-1671天)。结果显示活产、着床、临床妊娠、流产、低出生体重、早产率均无显著差异,冻存时长不影响活产、着床、临床妊娠、流产、出生体重或分娩孕周。

要点

  • 供卵 recipient 新鲜与冻融整倍体囊胚移植的活产、着床、临床妊娠、流产无显著差异。
  • 供卵 recipient 单胎活产中,新鲜与冻融单胚胎移植的低出生体重和早产率无显著差异。
  • 自体冻存整倍体单胚胎移植中,冻存21-1671天不影响活产、着床、临床妊娠、流产、出生体重或分娩孕周。

核心结论

  • 玻璃化冷冻与冻存(最长4年)是安全有效的做法,不显著影响胚胎移植后的临床结局。

研究设计与样本

  • 回顾性队列研究,比较供卵 recipient 新鲜(n=25)与玻璃化冻融(n=86)整倍体囊胚移植。
  • 比较供卵 recipient 单胎活产中新鲜(n=100)与冻融(n=102)单胚胎移植。
  • 分析自体冻存整倍体单胚胎移植(n=1760),冻存21-1671天。

主要发现

  • 第1组:新鲜与冻融囊胚活产OR 1.7(95%CI 0.5-5.9)、着床OR 0.9(95%CI 0.2-3.9)、临床妊娠OR 3.4(95%CI 0.9-13.0)、流产OR 1.2(95%CI 0.98-1.4)。
  • 第2组:新鲜与冻融囊胚低出生体重OR 0.44(95%CI 0.1-1.6)、早产OR 0.99(95%CI 0.4-2.3)。
  • 第3组:冻存时长对活产OR 1.0(95%CI 1.0-1.0)、着床OR 1.0(95%CI 0.99-1.01)、临床妊娠OR 1.0(95%CI 1.0-1.0)、流产OR 0.99(95%CI 1.0-1.0)、出生体重(β=-15.7)、分娩孕周(β=-0.996)无显著影响。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Does vitrification and warming affect live birth rate, infant birth weight and timing of delivery? DESIGN: Retrospective, cohort study comparing outcomes of donor oocyte recipient fresh (n = 25) versus vitrified (n = 86) euploid blastocyst transfers; donor oocyte recipient singleton live births from fresh (n = 100) versus vitrified (n = 102) single embryo transfers (SET); and autologous vitrified euploid SET (n = 1760) (cryostored 21-1671 days). RESULTS: Group 1: fresh and vitrified-warmed blastocysts had similar live birth (OR 1.7; 95% CI 0.5 to 5.9), implantation (OR 0.9; 95% CI 0.2 to 3.9), clinical pregnancy (OR 3.4; 95% CI 0.9 to 13.0) and pregnancy loss (OR 1.2; 95% CI 0.98 to 1.4); group 2: low birth weight (OR 0.44; 95% CI 0.1 to 1.6) and preterm delivery (0.99; 95% CI 0.4 to 2.3) rates were similar in fresh and vitrified-warmed blastocyst transfers; group 3: cryostorage duration did not affect live birth (OR 1.0; 95% CI 1.0 to 1.0), implantation (OR 1.0; 95% CI 0.99 to 1.01), clinical pregnancy (OR 1.0; 95% CI 1.0 to 1.0]), pregnancy loss (OR 0.99; 95% CI 1.0 to 1.0), birth weight (β = -15.7) or gestational age at delivery (β = -0.996). CONCLUSIONS: Vitrification and cryostorage (up to 4 years) are safe and effective practices that do not significantly affect clinical outcome after embryo transfer.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Sekhon L, Lee JA, Flisser E, et al. Blastocyst vitrification, cryostorage and warming does not affect live birth rate, infant birth weight or timing of delivery. Reprod Biomed Online. 2018. PMID: 29706285. doi:10.1016/j.rbmo.2018.03.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。